PEOPLE - Haemonetics makes appointment:
This article was originally published in Clinica
US automated blood processing systems developer Haemonetics has appointed Dr Harvey Klein and Colin Lind to its board of directors. Dr Klein is currently vice-president of the American Association of Blood Banks and Mr Lind is managing director of investment firm Richard C Blum & Associates.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.